The legacy success of copyright’s flagship drug has undeniably shaped the drug landscape. However, wagering in companies heavily dependent on biosimilars and the diminishing patent exclusivity https://adammxsr943574.wikigop.com/304021/the_blue_pill_and_pharma_a_uncertain_venture